Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Financial ResultsItem 2.02 · 8-KLOW RiskNeutral

HEARTSCIENCES INC.

heartsciences.com
Filed: Mar 16, 2026Southlake, TXCIK: 0001468492Healthcare
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

HeartSciences Inc. reported Q1 2026 financial results for the quarter ended January 31, 2026, providing shareholders with updates on the company's financial health and operational performance during the period.

Key Takeaways

HeartSciences issued Q1 2026 financial results on March 16, 2026 for the quarter ending January 31, 2026

The filing includes a press release with performance metrics and strategic business updates

2 more takeaways

Related Filings (1)

1 more filing from HEARTSCIENCES INC. in the last 90 days

Filing Overview

Form Type8-K
Filing DateMar 16, 2026
Item2.02
CategoryFinancial Results
CIK0001468492
Accession #hscs20251229_8k.htm
Risk LevelLOW
SentimentNeutral
Signalinformational
Topics
earnings

What This Means

The company is reporting financial results. Look for revenue trends, profitability changes, and forward guidance.
View Full Filing on SEC.govBrowse More Filings